A phase I dose expansion study of NBTXR3, radiation enhancing hafnium oxide nanoparticles, for the treatment of cisplatin-ineligible locally advanced HNSCC patients
Titel:
A phase I dose expansion study of NBTXR3, radiation enhancing hafnium oxide nanoparticles, for the treatment of cisplatin-ineligible locally advanced HNSCC patients
Auteur:
Le Tourneau, C. Calugaru, V. Moreno, V. Calvo, E. Liem, X. Salas, S. Doger, B. Jouffroy, T. Mirabel, X. Rodriguez, J. Chilles, A. Bernois, K. Fakhry, N. Wong Hee Kam, S. Hoffmann, C.